---
title: "Septerna SVP Drug Discovery Daniel D. Long sells USD 114,901.29 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295028601.md"
description: "Septerna Inc. SVP of Drug Discovery, Daniel D. Long, sold 3,334 common shares on August 3 under a 10b5-1 trading plan. The shares were sold at prices ranging from USD 33.98 to USD 34.68 per share, totaling approximately USD 114,901.29. Prior to the sale, Long exercised options for the same number of shares at USD 2.76 each. Following these transactions, he retained a holding of 96,412 shares."
datetime: "2026-08-05T23:17:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295028601.md)
  - [en](https://longbridge.com/en/news/295028601.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295028601.md)
---

# Septerna SVP Drug Discovery Daniel D. Long sells USD 114,901.29 in common shares

-   Septerna SVP, Drug Discovery Daniel D. Long sold 3,334 shares on Aug. 3 under a 10b5-1 plan. \* Sales priced at USD 33.98 and USD 34.68 per share. \* Long also exercised options for 3,334 shares at USD 2.76. \* He held 96,412 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Septerna Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-335820), on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SEPN.US](https://longbridge.com/en/quote/SEPN.US.md)

## Related News & Research

- [Janus Henderson Group PLC Purchases Shares of 890,754 Septerna, Inc. $SEPN](https://longbridge.com/en/news/294795769.md)
- [Septerna SVP Drug Discovery Daniel D. Long disposes of 15,000 common shares worth $548,782](https://longbridge.com/en/news/290749543.md)
- [Clarivate sees obesity drug market rising to $56.8 billion by 2033, flags next-generation therapy innovators](https://longbridge.com/en/news/294927591.md)
- [BUZZ-Street View: Growth drugs lift Pfizer outlook, but execution remains key](https://longbridge.com/en/news/294968791.md)
- [Egetis publishes corporate presentation on Emcitate launch, FDA review for MCT8 deficiency drug](https://longbridge.com/en/news/294971733.md)